FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386306021> ?p ?o ?g. }

• W4386306021 endingPage "1016" @default.
• W4386306021 startingPage "955" @default.
• W4386306021 abstract "The 16th Workshop on Recent Issues in Bioanalysis (16th WRIB) took place in Atlanta, GA, USA on September 26-30, 2022. Over 1000 professionals representing pharma/biotech companies, CROs, and multiple regulatory agencies convened to actively discuss the most current topics of interest in bioanalysis. The 16th WRIB included 3 Main Workshops and 7 Specialized Workshops that together spanned 1 week in order to allow exhaustive and thorough coverage of all major issues in bioanalysis, biomarkers, immunogenicity, gene therapy, cell therapy and vaccines. Moreover, in-depth workshops on the ICH M10 BMV final guideline (focused on this guideline training, interpretation, adoption and transition); mass spectrometry innovation (focused on novel technologies, novel modalities, and novel challenges); and flow cytometry bioanalysis (rising of the 3rd most common/important technology in bioanalytical labs) were the special features of the 16th edition. As in previous years, WRIB continued to gather a wide diversity of international, industry opinion leaders and regulatory authority experts working on both small and large molecules as well as gene, cell therapies and vaccines to facilitate sharing and discussions focused on improving quality, increasing regulatory compliance, and achieving scientific excellence on bioanalytical issues. This 2022 White Paper encompasses recommendations emerging from the extensive discussions held during the workshop and is aimed to provide the bioanalytical community with key information and practical solutions on topics and issues addressed, in an effort to enable advances in scientific excellence, improved quality and better regulatory compliance. Due to its length, the 2022 edition of this comprehensive White Paper has been divided into three parts for editorial reasons. This publication (Part 1A) covers the recommendations on Mass Spectrometry and ICH M10. Part 1B covers the Regulatory Agencies' Inputs on Bioanalysis, Biomarkers, Immunogenicity, Gene & Cell Therapy and Vaccine. Part 2 (LBA, Biomarkers/CDx and Cytometry) and Part 3 (Gene Therapy, Cell therapy, Vaccines and Biotherapeutics Immunogenicity) are published in volume 15 of Bioanalysis, issues 15 and 14 (2023), respectively." @default.
• W4386306021 created "2023-09-01" @default.
• W4386306021 creator A5000623880 @default.
• W4386306021 creator A5002106648 @default.
• W4386306021 creator A5003167445 @default.
• W4386306021 creator A5003445392 @default.
• W4386306021 creator A5003643199 @default.
• W4386306021 creator A5004699870 @default.
• W4386306021 creator A5005988952 @default.
• W4386306021 creator A5006487429 @default.
• W4386306021 creator A5008247815 @default.
• W4386306021 creator A5010162365 @default.
• W4386306021 creator A5010332456 @default.
• W4386306021 creator A5010886169 @default.
• W4386306021 creator A5012044636 @default.
• W4386306021 creator A5012677271 @default.
• W4386306021 creator A5013286857 @default.
• W4386306021 creator A5014334634 @default.
• W4386306021 creator A5015331743 @default.
• W4386306021 creator A5015653352 @default.
• W4386306021 creator A5016104625 @default.
• W4386306021 creator A5019166468 @default.
• W4386306021 creator A5019913014 @default.
• W4386306021 creator A5020369833 @default.
• W4386306021 creator A5020596586 @default.
• W4386306021 creator A5021272849 @default.
• W4386306021 creator A5023099731 @default.
• W4386306021 creator A5023147466 @default.
• W4386306021 creator A5024335537 @default.
• W4386306021 creator A5024782080 @default.
• W4386306021 creator A5025509670 @default.
• W4386306021 creator A5028357872 @default.
• W4386306021 creator A5031155500 @default.
• W4386306021 creator A5031456131 @default.
• W4386306021 creator A5032303034 @default.
• W4386306021 creator A5032764121 @default.
• W4386306021 creator A5032811645 @default.
• W4386306021 creator A5032927781 @default.
• W4386306021 creator A5033523181 @default.
• W4386306021 creator A5033565234 @default.
• W4386306021 creator A5033709745 @default.
• W4386306021 creator A5033891850 @default.
• W4386306021 creator A5035094817 @default.
• W4386306021 creator A5037753879 @default.
• W4386306021 creator A5038065851 @default.
• W4386306021 creator A5039222016 @default.
• W4386306021 creator A5040578796 @default.
• W4386306021 creator A5041974544 @default.
• W4386306021 creator A5042689320 @default.
• W4386306021 creator A5043361820 @default.
• W4386306021 creator A5044413711 @default.
• W4386306021 creator A5045229942 @default.
• W4386306021 creator A5048661780 @default.
• W4386306021 creator A5050264444 @default.
• W4386306021 creator A5051239108 @default.
• W4386306021 creator A5052242846 @default.
• W4386306021 creator A5054553933 @default.
• W4386306021 creator A5056326026 @default.
• W4386306021 creator A5056768459 @default.
• W4386306021 creator A5058778478 @default.
• W4386306021 creator A5058845265 @default.
• W4386306021 creator A5059043247 @default.
• W4386306021 creator A5062121176 @default.
• W4386306021 creator A5062601988 @default.
• W4386306021 creator A5064004252 @default.
• W4386306021 creator A5066843127 @default.
• W4386306021 creator A5067888779 @default.
• W4386306021 creator A5071763668 @default.
• W4386306021 creator A5073407699 @default.
• W4386306021 creator A5073736084 @default.
• W4386306021 creator A5074316818 @default.
• W4386306021 creator A5075517764 @default.
• W4386306021 creator A5075591900 @default.
• W4386306021 creator A5075592850 @default.
• W4386306021 creator A5076220745 @default.
• W4386306021 creator A5079593795 @default.
• W4386306021 creator A5081220752 @default.
• W4386306021 creator A5083302714 @default.
• W4386306021 creator A5084335443 @default.
• W4386306021 creator A5085938764 @default.
• W4386306021 creator A5086143640 @default.
• W4386306021 creator A5086737974 @default.
• W4386306021 creator A5087687578 @default.
• W4386306021 creator A5088666106 @default.
• W4386306021 creator A5089911601 @default.
• W4386306021 creator A5091727315 @default.
• W4386306021 creator A5092721460 @default.
• W4386306021 creator A5092721461 @default.
• W4386306021 date "2023-08-01" @default.
• W4386306021 modified "2023-10-14" @default.
• W4386306021 title "2022 White Paper on Recent Issues in Bioanalysis: ICH M10 BMV Guideline & Global Harmonization; Hybrid Assays; Oligonucleotides & ADC; Non-Liquid & Rare Matrices; Regulatory Inputs (<u>Part 1A</u> – Recommendations on Mass Spectrometry, Chromatography and Sample Preparation, Novel Technologies, Novel Modalities, and Novel Challenges, ICH M10 BMV Guideline & Global Harmonization <u>Part 1B</u> - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/CDx/BAV, …" @default.
• W4386306021 cites W2004638171 @default.
• W4386306021 cites W2008094382 @default.
• W4386306021 cites W2031160951 @default.
• W4386306021 cites W2046974419 @default.
• W4386306021 cites W2050903060 @default.
• W4386306021 cites W2052245601 @default.
• W4386306021 cites W2059183805 @default.

• next